Research For better living

news item:Successful submission of all dossiers before REACH deadline

We proudly announce that the Registration Services & Risk Assessment team of Triskelion enabled all of their REACH clients to comply with the 3 major legal deadlines in 2010, 2013 and 2018.

Years of helping clients with their registration strategies, data gap analyses, SIEF discussions, pushing for early action, outsourcing and monitoring studies, creating IUCLID files, preparing read-across justifications and exposure assessments paid off as we were able to send the final files and dossiers to the clients well before the final deadline of 31 May 2018.

By focusing on being proactive, applying strong project management techniques and putting our experience collected through years of service into practice, unpleasant surprises were kept to a minimum.

For substances with ongoing studies we ensured eligibility for the Directors Contact Group solutions. Our structured approaches and familiarity with relevant tools ensured that we could finalize quality dossiers in time.

All in all, thanks to good preparation and experience we were able to make our clients happy, delivering a few hundred high-quality REACH dossiers ranging from relatively simple dossiers  to very large dossiers with lots of data or extensive use of read-across and other alternative approaches. Simultaneously with these activities, we were also meeting the needs of our clients in the scope of the Biocidal Products Regulation.

And, of course, the REACH-related activities continue: dossiers have to be updated and resubmitted, the communication with ECHA on (draft) decisions and approval of test proposals continues, downstream user communication is getting more attention and clients need support in the scope of restriction or authorization processes.

We look back on fruitful and successful cooperation with our clients before the REACH deadline and we look forward to continuing our support for the chemical industry with our regulatory services in the future.